Singapore markets close in 30 minutes
Explore/

The fight against COVID19

The fight against COVID19

23.82k followers14 symbols Watchlist by TREA

Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.

Curated by TREA

TREA analyses over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: US FDA (US Food and Drug Administration), US NIH (US National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history of at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2, among others.

14 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
JNJJohnson & Johnson151.27-2.13-1.39%4:00 pm GMT-47.47M7.43M364.06B
ABBVAbbVie Inc.164.56-1.86-1.12%4:00 pm GMT-43.01M5.60M290.59B
PFEPfizer Inc.28.53-0.11-0.38%4:00 pm GMT-421.56M42.53M161.67B
SNYSanofi48.42-0.25-0.51%4:00 pm GMT-41.24M1.98M121.10B
REGNRegeneron Pharmaceuticals, Inc.987.27+4.98+0.51%4:00 pm GMT-4310.81k456.29k108.78B
GSKGSK plc44.59-0.39-0.87%4:00 pm GMT-45.15M3.16M93.22B
GILDGilead Sciences, Inc.67.9+0.18+0.27%4:00 pm GMT-43.68M6.93M84.59B
MRNAModerna, Inc.141.01+8.11+6.10%4:00 pm GMT-44.47M3.84M54.04B
TAKTakeda Pharmaceutical Company Limited13.28+0.06+0.45%4:00 pm GMT-4594.35k1.63M41.95B
BNTXBioNTech SE92.47+1.86+2.05%4:00 pm GMT-4340.91k593.72k22.28B
NVAXNovavax, Inc.14.79+1.78+13.68%4:00 pm GMT-414.03M13.08M2.18B
VIRVir Biotechnology, Inc.9.69-0.04-0.41%4:00 pm GMT-4551.31k971.32k1.32B
INOInovio Pharmaceuticals, Inc.11.11-0.89-7.42%4:00 pm GMT-4338.94k442.74k287.87M
  • The Wall Street Journal

    GSK Sees Positive Results for Severe Asthma Treatment Depemokimab

    GSK said two late-stage trials of an asthma drug that could have peak sales of almost $4 billion met their goals.

  • GlobeNewswire

    Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration

    Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration Paris, New York, N.Y., and San Francisco, CA, May 21, 2024. Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle. This represents a first collaboration of its kind w

  • GlobeNewswire

    Sanofi: Information concerning the total number of voting rights and shares - April 2024

    Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,529,599,938 €Registered office : 46, avenue de la Grande Armée - 75017 Paris - FranceRegistered at the Paris Commercial and Companies Regi